Click to view our statement on Accessibility

Popular Searches

Back
Foley Viewpoints

The Foreign Corrupt Practices Act: Risk-Management and Compliance Strategies For Life Sciences and Pharmaceutical Companies

October 16, 2009

Author(s)

Gregory Husisian

Washington, D.C. 202.945.6149

Related Insights

View All Posts
July 16, 2025 Foley Viewpoints

Changes to the College and University Endowment Tax

The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…
July 16, 2025 Health Care Law Today Podcast

Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance

In this episode, Monica Chmielewski, vice chair of Foley’s Health Care Practice Group and Shannon Sumner, Chief Compliance Officer and Nashville’s Office Managing Principal of PYA explore how supply chain compliance is affecting the health care industry and share the risks and penalties associated with not being in compliance.
July 15, 2025 Innovative Technology Insights

Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development

In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…